This product is intended for laboratory research use only.
Not for human or veterinary use.
Not approved for diagnostic, therapeutic, or medical applications.
Handle using appropriate laboratory safety procedures and personal protective equipment.
Adamax is a synthetic research peptide developed for central nervous system research applications, with structural design likely incorporating adamantyl-group modifications (a chemistry approach commonly used in neurogenic peptide research to enhance blood-brain barrier penetration and proteolytic stability). The compound is positioned for research investigating neurogenic peptide pharmacology, BDNF pathway endpoints, and CNS cell biology research models. The "Adam-" naming convention in research peptide nomenclature typically references adamantyl-modified structures — a chemistry approach pioneered for compounds like P21 (Iqbal lab CNTF mimetic) and related BBB-penetrating neurogenic peptide analogs. Researchers working with this compound should verify the specific chemistry against the supplier's Certificate of Analysis (COA) and rely on MS-verified molecular weight as the primary identity confirmation prior to any research application.
• CNS peptide pharmacology — studied as a research compound for central nervous system cell biology research
• BDNF pathway research — investigated for BDNF gene expression endpoints in neuronal cell research models
• Adamantyl-modified peptide chemistry — explored for the effect of lipophilic adamantyl modifications on peptide stability and pharmacokinetics
• Comparative SAR research — examined alongside other adamantyl-modified neurogenic peptide research compounds (P21, related Iqbal-lab analogs)
• Neuronal cell biology research — researched for neuronal cell biology endpoints in cell culture research models
• Gene expression panels in neuronal cell research models
• BDNF gene and protein expression in neuronal cell research
• Comparative pharmacology versus other CNS research peptides and adamantyl-modified analogs
• Molecular weight characterization and MS-based identity verification
• Plasma stability and peptidase resistance research
• Form: Lyophilized white powder
• Net Peptide Content: 14 mg per vial
• Quantity: 1 vial
• Appearance: White to off-white lyophilizate
• Reconstitution: Bacteriostatic or sterile water (added by the end researcher)
• Purity: ≥99% by HPLC
• Identity: MS-verified (per COA)
• Storage: Protect from light
• Compound: Adamax
• Synonyms: CNS research peptide; adamantyl-modified neurogenic peptide research analog
• Class: Synthetic research peptide; likely adamantyl-modified structure (verify against supplier specifications)
• Sequence: Verify against batch COA (supplier-specific chemistry)
• Origin: Synthetic research compound for CNS pharmacology research
• Formula / M.W.: Verify against batch COA
• CAS: Verify against supplier COA
⚠️ Disclaimer
COA Verification Notice: Even if the vial label or product image states a certain concentration, always go by the COA for the true verified value. We reference the COA to determine the verified concentration and purity of each product, regardless of what the label or product image indicates.
Every batch ships with a matching Certificate of Analysis. The batch number printed on your vial corresponds directly to its published certificate. Verify any batch on our Testing & COAs page.
Orders placed before 5 PM ET ship the same business day via Xpresspost. Most Canadian addresses receive delivery within 1–2 business days. Free shipping applies automatically on orders over $200.
Store refrigerated at 2–8 °C, protected from light. For laboratory research use only — not for human consumption.
